Search

Your search keyword '"Mycophenolic Acid"' showing total 19,673 results
Start Over Descriptor "Mycophenolic Acid"

Refine your results

19,673 results on '"Mycophenolic Acid"'

21. Minitransplants With HLA-matched Donors : Comparison Between 2 GVHD Prophylaxis Regimens

Author

AZ Sint-Jan AV, Ziekenhuis Netwerk Antwerpen (ZNA), Jules Bordet Institute, University Hospital, Gasthuisberg, AZ-VUB, Cliniques universitaires Saint-Luc- Université Catholique de Louvain, University Hospital, Antwerp, Cliniques Universitaires de Mont-Godinne, Hospital de Jolimont, University Hospital, Ghent, AZ Delta, and Yves Beguin, Prof

Published
2024

47. Methotrexate and Mycophenolate Mofetil for UVEITIS (FAST)

Author

Aravind Eye Hospitals, India, Oregon Health and Science University, Asociación para Evitar la Ceguera en México, Royal Victoria Eye and Ear Hospital, Northwestern University, National Eye Institute (NEI), and King Khaled Eye Specialist Hospital

Published
2024

49. Astaxanthin and meclizine extend lifespan in UM-HET3 male mice; fisetin, SG1002 (hydrogen sulfide donor), dimethyl fumarate, mycophenolic acid, and 4-phenylbutyrate do not significantly affect lifespan in either sex at the doses and schedules used.

Author

Harrison, David, Strong, Randy, Reifsnyder, Peter, Rosenthal, Nadia, Korstanje, Ron, Fernandez, Elizabeth, Flurkey, Kevin, Ginsburg, Brett, Murrell, Meredith, Javors, Martin, Lopez-Cruzan, Marisa, Nelson, James, Willcox, Bradley, Allsopp, Richard, Watumull, David, Kirkland, James, Tchkonia, Tamar, Choi, Young, Yousefzadeh, Matthew, Robbins, Paul, Mitchell, James, Acar, Murat, Sarnoski, Ethan, Bene, Michael, Salmon, Adam, Kumar, Navasuja, Miller, Richard, and Cortopassi, Gino

Subjects
4-Phenylbutyrate (PBA), Astaxanthin (Asta), Dimethyl Fumarate (DMF), Fisetin (Fis), Heterogeneous mice, Lifespan, Meclizine (Mec), Mycophenolic acid (MPA), SG1002, Female, Mice, Male, Animals, Longevity, Meclizine, Hydrogen Sulfide, Dimethyl Fumarate, Mycophenolic Acid, Phenylbutyrates, Xanthophylls, Flavonols
Abstract

In genetically heterogeneous (UM-HET3) mice produced by the CByB6F1 × C3D2F1 cross, the Nrf2 activator astaxanthin (Asta) extended the median male lifespan by 12% (p = 0.003, log-rank test), while meclizine (Mec), an mTORC1 inhibitor, extended the male lifespan by 8% (p = 0.03). Asta was fed at 1840 ± 520 (9) ppm and Mec at 544 ± 48 (9) ppm, stated as mean ± SE (n) of independent diet preparations. Both were started at 12 months of age. The 90th percentile lifespan for both treatments was extended in absolute value by 6% in males, but neither was significant by the Wang-Allison test. Five other new agents were also tested as follows: fisetin, SG1002 (hydrogen sulfide donor), dimethyl fumarate, mycophenolic acid, and 4-phenylbutyrate. None of these increased lifespan significantly at the dose and method of administration tested in either sex. Amounts of dimethyl fumarate in the diet averaged 35% of the target dose, which may explain the absence of lifespan effects. Body weight was not significantly affected in males by any of the test agents. Late life weights were lower in females fed Asta and Mec, but lifespan was not significantly affected in these females. The male-specific lifespan benefits from Asta and Mec may provide insights into sex-specific aspects of aging.

Published
2024

Catalog

Books, media, physical & digital resources
See catalog results